Penumbra (PEN) Enterprise Value (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.00% |
| Dec 31, 2025 | -15.85% |
| Sep 30, 2025 | -10.77% |
| Jun 30, 2025 | -12.07% |
| Mar 31, 2025 | -11.38% |
| Dec 31, 2024 | -16.87% |
| Sep 30, 2024 | 14.33% |
| Jun 30, 2024 | -8.36% |
| Mar 31, 2024 | -8.40% |
| Dec 31, 2023 | -16.21% |
| Sep 30, 2023 | -12.57% |
| Jun 30, 2023 | -11.03% |
| Mar 31, 2023 | -5.89% |
| Dec 31, 2022 | -1.95% |
| Sep 30, 2022 | 9.76% |
| Jun 30, 2022 | 14.97% |
| Mar 31, 2022 | 5.70% |
| Dec 31, 2021 | 6.68% |
| Sep 30, 2021 | -74.27% |
| Jun 30, 2021 | 36.61% |
| Mar 31, 2021 | 7.94% |
| Dec 31, 2020 | 1.06% |
| Sep 30, 2020 | 3.04% |
| Jun 30, 2020 | -65.60% |
| Mar 31, 2020 | 10.88% |
| Dec 31, 2019 | 2.65% |
| Sep 30, 2019 | -4.10% |
| Jun 30, 2019 | -11.97% |
| Mar 31, 2019 | 16.72% |
| Dec 31, 2018 | -3.43% |
| Sep 30, 2018 | 6.21% |
| Jun 30, 2018 | 2.99% |
| Mar 31, 2018 | 0.61% |
| Dec 31, 2017 | 1.93% |
| Sep 30, 2017 | -0.08% |
| Jun 30, 2017 | 5.61% |
| Mar 31, 2017 | -79.91% |
| Dec 31, 2016 | 9.22% |
| Sep 30, 2016 | -1.41% |
| Jun 30, 2016 | 3.15% |
| Mar 31, 2016 | 2.95% |
| Dec 31, 2015 | 6.47% |
| Sep 30, 2015 | -332.75% |
| Jun 30, 2015 | -352.09% |
| Mar 31, 2015 | 84.22% |
| Dec 31, 2014 | -529.49% |